Suppr超能文献

腹部嗜铬细胞瘤术后复发转移的 CT 影像学特征及预测因素分析。

An Analysis of Computed Tomography Imaging Features and Predictive Factors for Postoperative Recurrence and Metastasis of Abdominal Paragangliomas.

机构信息

Department of Radiology, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang, China.

Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.

出版信息

Contrast Media Mol Imaging. 2022 Feb 21;2022:8638588. doi: 10.1155/2022/8638588. eCollection 2022.

Abstract

METHODS

We studied 51 abdominal PGL patients at the First Affiliated Hospital of Bengbu Medical College, Tongde Hospital, and Sir Run Shaw Hospital, Hangzhou, Zhejiang Province, China, from June 2009 to May 2019. Thereafter, the clinical research data, tumor biomarkers, and CT features were compared between the aggressive PGLs and the nonaggressive PGLs using independent-samples -tests and chi-square tests.

RESULTS

Of the 51 cases, 43 were benign and 8 had malignant tendencies. Postoperative recurrence and metastasis were more likely to occur when the tumor diameter was >8 cm or/and the enhancement degree was not obvious. Clinical symptoms, tumor markers, sex, age, and CT image characteristics including morphology, presence of cystic degeneration, "pointed peach" sign, calcification, hemorrhage, enlarged lymph nodes, and peritumor and intratumor blood vessels were not significantly different between the two groups ( > 0.05).

CONCLUSION

Our findings suggest that CT features, including size >8 cm and enhancement degree, could provide important evidence to assess risk factors for aggressive PGLs.

摘要

方法

本研究纳入了 2009 年 6 月至 2019 年 5 月于蚌埠医学院第一附属医院、同德医院和浙江大学附属邵逸夫医院就诊的 51 例腹型嗜铬细胞瘤患者。此后,采用独立样本 t 检验和卡方检验比较侵袭性 PGL 和非侵袭性 PGL 的临床研究数据、肿瘤标志物和 CT 特征。

结果

51 例患者中,43 例为良性,8 例具有恶性倾向。当肿瘤直径>8cm 或/和增强程度不明显时,更有可能发生术后复发和转移。两组间的临床症状、肿瘤标志物、性别、年龄、CT 图像特征(包括形态、囊变、“ pointed peach”征、钙化、出血、淋巴结肿大、肿瘤周围和肿瘤内血管)差异均无统计学意义(>0.05)。

结论

我们的研究结果表明,CT 特征(包括大小>8cm 和增强程度)可为评估侵袭性 PGL 的危险因素提供重要依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d86/8885278/f07d55fb5406/CMMI2022-8638588.001.jpg

相似文献

1
An Analysis of Computed Tomography Imaging Features and Predictive Factors for Postoperative Recurrence and Metastasis of Abdominal Paragangliomas.
Contrast Media Mol Imaging. 2022 Feb 21;2022:8638588. doi: 10.1155/2022/8638588. eCollection 2022.
3
CT and MR Imaging Findings of Pancreatic Paragangliomas: A Case Report.
Medicine (Baltimore). 2016 Mar;95(9):e2959. doi: 10.1097/MD.0000000000002959.
4
A rare case of multiple paragangliomas in the head and neck, retroperitoneum and duodenum: A case report and review of the literature.
Front Endocrinol (Lausanne). 2023 Jan 10;13:1054468. doi: 10.3389/fendo.2022.1054468. eCollection 2022.
5
[Analysis on CT in diagnosis of lymph node metastasis of thoracic esophageal cancer with minimum diameter greater than 1 cm].
Zhonghua Wai Ke Za Zhi. 2019 Aug 1;57(8):601-606. doi: 10.3760/cma.j.issn.0529-5815.2019.08.008.
6
GROWTH RATE OF PARAGANGLIOMAS RELATED TO GERMLINE MUTATIONS OF THE SDHX GENES.
Endocr Pract. 2017 Mar;23(3):342-352. doi: 10.4158/EP161377.OR. Epub 2016 Dec 14.
7
Pilocytic astrocytoma: correlation between the initial imaging features and clinical aggressiveness.
AJR Am J Roentgenol. 1993 Aug;161(2):369-72. doi: 10.2214/ajr.161.2.8333380.
8
Malignant extra-adrenal pancreatic paraganglioma: case report and literature review.
BMC Cancer. 2013 Oct 20;13:486. doi: 10.1186/1471-2407-13-486.
9
A correlation research of Ki67 index, CT features, and risk stratification in gastrointestinal stromal tumor.
Cancer Med. 2018 Sep;7(9):4467-4474. doi: 10.1002/cam4.1737. Epub 2018 Aug 19.
10
Colorectal paragangliomas with immunohistochemical deficiency of succinate dehydrogenase subunit B.
Endocr J. 2022 May 30;69(5):523-528. doi: 10.1507/endocrj.EJ21-0630. Epub 2021 Dec 1.

本文引用的文献

1
Metastatic Pheochromocytomas and Abdominal Paragangliomas.
J Clin Endocrinol Metab. 2021 Apr 23;106(5):e1937-e1952. doi: 10.1210/clinem/dgaa982.
2
Pheochromocytoma and Paraganglioma: From Epidemiology to Clinical Findings.
Sisli Etfal Hastan Tip Bul. 2020 Jun 3;54(2):159-168. doi: 10.14744/SEMB.2020.18794. eCollection 2020.
3
Management and outcome of metastatic pheochromocytomas/paragangliomas: an overview.
J Endocrinol Invest. 2021 Jan;44(1):15-25. doi: 10.1007/s40618-020-01344-z. Epub 2020 Jun 29.
4
Overview of primary adult retroperitoneal tumours.
Eur J Surg Oncol. 2020 Sep;46(9):1573-1579. doi: 10.1016/j.ejso.2020.04.054. Epub 2020 May 21.
5
A Guide to Pheochromocytomas and Paragangliomas.
Surg Pathol Clin. 2019 Dec;12(4):951-965. doi: 10.1016/j.path.2019.08.009. Epub 2019 Sep 28.
6
Disease monitoring of patients with pheochromocytoma or paraganglioma by biomarkers and imaging studies.
Best Pract Res Clin Endocrinol Metab. 2020 Mar;34(2):101347. doi: 10.1016/j.beem.2019.101347. Epub 2019 Oct 21.
7
Pheochromocytoma.
Endocr Regul. 2019 Jul 1;53(3):191-212. doi: 10.2478/enr-2019-0020.
8
Diagnostic Accuracy of Computed Tomography to Exclude Pheochromocytoma: A Systematic Review, Meta-analysis, and Cost Analysis.
Mayo Clin Proc. 2019 Oct;94(10):2040-2052. doi: 10.1016/j.mayocp.2019.03.030. Epub 2019 Sep 9.
9
Hepatic metastatic paraganglioma 12 years after retroperitoneal paraganglioma resection: a case report.
BMC Gastroenterol. 2019 Aug 8;19(1):142. doi: 10.1186/s12876-019-1061-6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验